Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis
出版年份 2021 全文链接
标题
Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis
作者
关键词
-
出版物
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2021-01-01
DOI
10.1093/jpp/rgaa063
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of statins on Parkinsonʼs disease
- (2019) Junqiang Yan et al. MEDICINE
- Parkinson's Disease and Parkinsonism
- (2019) Michael T Hayes AMERICAN JOURNAL OF MEDICINE
- Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
- (2019) Irina Alecu et al. Frontiers in Neuroscience
- Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease
- (2019) Uram Jin et al. Experimental Neurobiology
- 27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons
- (2018) Jared Schommer et al. BMC NEUROSCIENCE
- Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
- (2018) Amin Karimi-Moghadam et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein
- (2018) Tammy Ryan et al. Nature Communications
- A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition
- (2018) Talia Zeppelin et al. PLoS Computational Biology
- Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study
- (2018) Violetta Rozani et al. MOVEMENT DISORDERS
- Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice
- (2018) Rajib Paul et al. NEUROSCIENCE
- Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment
- (2018) Saranna Fanning et al. MOLECULAR CELL
- Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity
- (2018) Benjamin M. Vincent et al. Cell Reports
- The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease
- (2017) Courtney Lane-Donovan et al. JOURNAL OF LIPID RESEARCH
- Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
- (2017) Fatemeh Nouri Emamzadeh JOURNAL OF MOLECULAR NEUROSCIENCE
- Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells
- (2017) Elena Chiricozzi et al. JOURNAL OF NEUROCHEMISTRY
- α-Synuclein Regulates Neuronal Cholesterol Efflux
- (2017) Jen-Hsiang Hsiao et al. MOLECULES
- Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
- (2017) Guodong Liu et al. MOVEMENT DISORDERS
- Low LDL cholesterol,PCSK9andHMGCRgenetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
- (2017) Marianne Benn et al. BMJ-British Medical Journal
- Statins and Cognition in Parkinson’s Disease
- (2017) Benjamin L. Deck et al. Journal of Parkinsons Disease
- Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress
- (2017) Camille B. Carroll et al. Journal of Parkinsons Disease
- Low LDL cholesterol,PCSK9andHMGCRgenetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
- (2017) Marianne Benn et al. BMJ-British Medical Journal
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson’s disease: Involvement of mitochondrial dysfunctions and oxidative stress
- (2017) Rajib Paul et al. PLoS One
- Cholesterol Biosynthesis: A Mechanistic Overview
- (2016) Nuno M. F. S. A. Cerqueira et al. BIOCHEMISTRY
- Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease
- (2016) Margaux Doria et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease
- (2016) Fatemeh Nouri Emamzadeh et al. NEUROSCIENCE LETTERS
- Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes
- (2015) Andreas van Maarschalkerweerd et al. FEBS LETTERS
- Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease
- (2015) Kyle Farmer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients
- (2015) Christine R. Swanson et al. MOVEMENT DISORDERS
- Cholesterol – A putative endogenous contributor towards Parkinson's disease
- (2015) Rajib Paul et al. NEUROCHEMISTRY INTERNATIONAL
- Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies
- (2015) Keiko Nakamura et al. NEUROPATHOLOGY
- 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
- (2015) Min-Yu Sun et al. NEUROSCIENTIST
- Cholesterol metabolism and homeostasis in the brain
- (2015) Juan Zhang et al. Protein & Cell
- HDL and cholesterol handling in the brain
- (2014) C. Vitali et al. CARDIOVASCULAR RESEARCH
- Cholesterol in brain disease: sometimes determinant and frequently implicated
- (2014) M. G. Martin et al. EMBO REPORTS
- The serum lipid profile of Parkinson's disease patients: a study from China
- (2014) Xiaoyan Guo et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Acceleration of α-Synuclein Aggregation by Exosomes
- (2014) Marie Grey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasma apolipoprotein A1 as a biomarker for Parkinson disease
- (2013) Judy K. Qiang et al. ANNALS OF NEUROLOGY
- Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
- (2013) Gaurav V. Harlalka et al. BRAIN
- Recent advances in physiological lipoprotein metabolism
- (2013) Indra Ramasamy CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Lifelong Expression of Apolipoprotein D in the Human Brainstem: Correlation with Reduced Age-Related Neurodegeneration
- (2013) Ana Navarro et al. PLoS One
- Importance of cholesterol in dopamine transporter function
- (2012) Kymry T. Jones et al. JOURNAL OF NEUROCHEMISTRY
- Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
- (2012) Gusheng Wu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
- (2011) Grit Taschenberger et al. ACTA NEUROPATHOLOGICA
- The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain
- (2011) Jacques Fantini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells
- (2011) Kye-Young Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion
- (2011) Jacques Fantini et al. JOURNAL OF MOLECULAR BIOLOGY
- Unknown
- (2011) Noemi Fabelo et al. MOLECULAR MEDICINE
- Prospects of Statins in Parkinson Disease
- (2011) Avik Roy et al. NEUROSCIENTIST
- Apolipoproteins in the brain: implications for neurological and psychiatric disorders
- (2010) David A Elliott et al. Clinical Lipidology
- Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding
- (2010) Weimin C. Hong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Central nervous system: cholesterol turnover, brain development and neurodegeneration
- (2009) John M. Dietschy BIOLOGICAL CHEMISTRY
- Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
- (2009) Andrew O. Koob et al. EXPERIMENTAL NEUROLOGY
- Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor
- (2009) Lorraine N. Clark et al. PARKINSONISM & RELATED DISORDERS
- Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties
- (2008) Timothy J Cunningham et al. Journal of Inflammation-London
- Role of ATP-binding cassette transporters in brain lipid transport and neurological disease
- (2008) Woojin Scott Kim et al. JOURNAL OF NEUROCHEMISTRY
- Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and α-synuclein in human neuroblastoma SH-SY5Y cells
- (2008) Jaya Prasanthi Rantham Prabhakara et al. JOURNAL OF NEUROCHEMISTRY
- Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
- (2008) Xuemei Huang et al. MOVEMENT DISORDERS
- Lipid rafts, cholesterol, and the brain
- (2008) Zeljka Korade et al. NEUROPHARMACOLOGY
- Early α-synuclein lipoxidation in neocortex in Lewy body diseases
- (2006) Esther Dalfó et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started